Group One Trading’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6
| Closed | -$2K | – | 8807 |
|
|
2022
Q1 | $2K | Sell |
6
-19
| -76% | -$12.1K | ﹤0.01% | 7779 |
|
|
2021
Q4 | $25K | Sell |
25
-6
| -19% | -$8.46K | ﹤0.01% | 6852 |
|
|
2021
Q3 | $59K | Buy |
31
+5
| +19% | +$11.3K | ﹤0.01% | 6420 |
|
|
2021
Q2 | $70K | Sell |
26
-92
| -78% | -$303K | ﹤0.01% | 6296 |
|
|
2021
Q1 | $490K | Buy |
118
+86
| +269% | +$465K | ﹤0.01% | 4062 |
|
|
2020
Q4 | $181K | Buy |
32
+21
| +191% | +$124K | ﹤0.01% | 4127 |
|
|
2020
Q3 | $70K | Sell |
11
-24
| -69% | -$138K | ﹤0.01% | 4425 |
|
|
2020
Q2 | $193K | Buy |
35
+28
| +400% | +$145K | ﹤0.01% | 3413 |
|
|
2020
Q1 | $26K | Sell |
7
-4
| -36% | -$23K | ﹤0.01% | 4103 |
|
|
2019
Q4 | $53K | Buy |
11
+2
| +22% | +$6.99K | ﹤0.01% | 3982 |
|
|
2019
Q3 | $22K | Buy |
9
+3
| +50% | +$7.39K | ﹤0.01% | 4327 |
|
|
2019
Q2 | $19K | Sell |
6
-9
| -60% | -$25.1K | ﹤0.01% | 4202 |
|
|
2019
Q1 | $44K | Buy |
15
+12
| +400% | +$25.4K | ﹤0.01% | 3628 |
|
|
2018
Q4 | $4K | Buy |
3
+2
| +200% | +$3.06K | ﹤0.01% | 4542 |
|
|
2018
Q3 | $1K | Buy |
+1
| New | +$732 | ﹤0.01% | 5095 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | -$4K | – | 5600 |
|
|
2018
Q1 | $4K | Sell |
1
-6
| -86% | -$39.7K | ﹤0.01% | 4568 |
|
|
2017
Q4 | $40K | Buy |
+7
| New | +$65.2K | ﹤0.01% | 3842 |
|
Other funds holding AGRX
Group One Trading's AGRX Position: Q1 2024 in Review
Group One Trading sold out of Agile Therapeutics (AGRX) in Q1 2024, closing a stake of 10 shares — an estimated $20 sold.
Group One Trading first reported a position in AGRX in Q4 2017 and held it in 25 quarters. The position peaked at $260K in Q3 2020. 1 fund tracked by Wall St. Rank holds AGRX as of Q1 2024.
- Group One Trading reported no remaining Agile Therapeutics position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 10 Agile Therapeutics shares in Q1 2024, an estimated $20.
- Group One Trading first reported a position in Agile Therapeutics in Q4 2017 and held it in 25 quarters.
- Group One Trading's Agile Therapeutics position peaked at $260K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Agile Therapeutics as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.